The Beauty Health Company logo SKIN - The Beauty Health Company

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 4
HOLD 7
SELL 3
STRONG
SELL 0
| PRICE TARGET: $1.53 DETAILS
HIGH: $2.00
LOW: $1.00
MEDIAN: $1.60
CONSENSUS: $1.53
UPSIDE: 122.48%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 85% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Undervalued Strong
Trading 70.9% below fair value
Current Price $0.69
Bear Case $2.36 243.5% upside ($2.36 - $0.69) / $0.69 = 243.5% 3% stage 1 growth, 11% discount
Fair Value $2.36 243.5% upside ($2.36 - $0.69) / $0.69 = 243.5% 3% stage 1 growth, 11% discount
Bull Case $2.59 276.9% upside ($2.59 - $0.69) / $0.69 = 276.9% 4% stage 1 growth, 11% discount

Adjust Assumptions

3.0%
11.0%
3.0%

Key Value Driver

FCF growth rate (3% base case)

Terminal Value % of EV 33%
Implied Market Multiple 6.3x

Plain-Language Summary

Our base-case estimate uses a two-stage discounted cash flow model based on free cash flow. We then blend that result with the average analyst price target of $1.53 from 14 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $2.36 per share.

Warnings

ℹ Wall Street's average price target is $1.53 (from 14 analysts). Our estimate is 68% above the consensus -- consider that gap carefully.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions